295 related articles for article (PubMed ID: 25895111)
1. Lipidomic Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative Colitis and Crohn's Disease.
Fan F; Mundra PA; Fang L; Galvin A; Moore XL; Weir JM; Wong G; White DA; Chin-Dusting J; Sparrow MP; Meikle PJ; Dart AM
Inflamm Bowel Dis; 2015 Jul; 21(7):1511-8. PubMed ID: 25895111
[TBL] [Abstract][Full Text] [Related]
2. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A.
Oriishi T; Sata M; Toyonaga A; Sasaki E; Tanikawa K
Gut; 1995 Jun; 36(6):891-6. PubMed ID: 7615279
[TBL] [Abstract][Full Text] [Related]
4. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
5. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
6. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
8. Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors.
Jacenik D; Cygankiewicz AI; Mokrowiecka A; Małecka-Panas E; Fichna J; Krajewska WM
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261736
[TBL] [Abstract][Full Text] [Related]
9. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
[TBL] [Abstract][Full Text] [Related]
10. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
[TBL] [Abstract][Full Text] [Related]
12. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
[TBL] [Abstract][Full Text] [Related]
13. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
[TBL] [Abstract][Full Text] [Related]
14. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining.
Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y
Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941
[TBL] [Abstract][Full Text] [Related]
15. A novel pathogenic role for microvasculature in inflammatory bowel disease.
Danese S; Papa A; Scaldaferri F; Graziani C; Bonizzi M; Armuzzi A; Fedeli G; Gasbarrini G; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2006; 10(1):3-5. PubMed ID: 16494103
[TBL] [Abstract][Full Text] [Related]
16. High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females.
Saruta M; Targan SR; Mei L; Ippoliti AF; Taylor KD; Rotter JI
Inflamm Bowel Dis; 2009 Mar; 15(3):321-7. PubMed ID: 18942751
[TBL] [Abstract][Full Text] [Related]
17. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
[TBL] [Abstract][Full Text] [Related]
18. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
[TBL] [Abstract][Full Text] [Related]
19. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
20. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
Zhang P; Liu X; Guo A; Xiong J; Fu Y; Zou K
Dig Dis Sci; 2016 Sep; 61(9):2608-18. PubMed ID: 27056038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
